High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$86K
$86,588
Total Sells (Filtered)
$900K
$900,774
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| AKBA |
Akebia Therapeutics, Inc.
|
CEO
Discretionary Buy
|
2026-03-04 | $86,588 | P | Form 4 |
| AKBA |
Akebia Therapeutics, Inc.
|
CEO
Sell to Cover
|
2026-02-02 | $133,530 | S | Form 4 |
| AKBA |
Akebia Therapeutics, Inc.
|
CEO
Sell to Cover
|
2026-02-02 | $159,698 | S | Form 4 |
| AKBA |
Akebia Therapeutics, Inc.
|
CEO
Sell to Cover
|
2026-02-02 | $116,328 | S | Form 4 |
|
AKBA
S
Akebia Therapeutics, Inc.
Burke Steven Keith
• Officer • SVP, Chief Medical Officer
Sell to Cover
2026-02-02
$29,999
|
||||||
| AKBA |
Akebia Therapeutics, Inc.
|
Officer • SVP, Chief Medical Officer
Sell to Cover
|
2026-02-02 | $29,999 | S | Form 4 |
|
AKBA
S
Akebia Therapeutics, Inc.
Burke Steven Keith
• Officer • SVP, Chief Medical Officer
Sell to Cover
2026-02-02
$35,271
|
||||||
| AKBA |
Akebia Therapeutics, Inc.
|
Officer • SVP, Chief Medical Officer
Sell to Cover
|
2026-02-02 | $35,271 | S | Form 4 |
|
AKBA
S
Akebia Therapeutics, Inc.
Burke Steven Keith
• Officer • SVP, Chief Medical Officer
Sell to Cover
2026-02-02
$28,774
|
||||||
| AKBA |
Akebia Therapeutics, Inc.
|
Officer • SVP, Chief Medical Officer
Sell to Cover
|
2026-02-02 | $28,774 | S | Form 4 |
|
AKBA
S
Akebia Therapeutics, Inc.
Grund Nicholas
• Officer • Chief Commercial Officer
Sell to Cover
2026-02-02
$74,483
|
||||||
| AKBA |
Akebia Therapeutics, Inc.
|
Officer • Chief Commercial Officer
Sell to Cover
|
2026-02-02 | $74,483 | S | Form 4 |
| AKBA |
Akebia Therapeutics, Inc.
|
CEO
Sell to Cover
|
2026-02-02 | $64,857 | S | Form 4 |
| AKBA |
Akebia Therapeutics, Inc.
|
CFO
Sell to Cover
|
2026-02-02 | $48,582 | S | Form 4 |
|
AKBA
S
Akebia Therapeutics, Inc.
Malabre Richard C
• Officer • SVP, Chief Accounting Officer
Sell to CoverΔOwn -10.4%
2026-02-02
$50,237
|
||||||
| AKBA |
Akebia Therapeutics, Inc.
|
Officer • SVP, Chief Accounting Officer
Sell to CoverΔOwn -10.4%
|
2026-02-02 | $50,237 | S | Form 4 |
|
AKBA
S
Akebia Therapeutics, Inc.
Malabre Richard C
• Officer • SVP, Chief Accounting Officer
Sell to Cover
2026-02-02
$18,601
|
||||||
| AKBA |
Akebia Therapeutics, Inc.
|
Officer • SVP, Chief Accounting Officer
Sell to Cover
|
2026-02-02 | $18,601 | S | Form 4 |
|
AKBA
S
Akebia Therapeutics, Inc.
Rucci Carolyn M.
• Officer • SVP, Chief Legal Officer
Sell to Cover
2026-02-02
$23,416
|
||||||
| AKBA |
Akebia Therapeutics, Inc.
|
Officer • SVP, Chief Legal Officer
Sell to Cover
|
2026-02-02 | $23,416 | S | Form 4 |
|
AKBA
S
Akebia Therapeutics, Inc.
Rucci Carolyn M.
• Officer • SVP, Chief Legal Officer
Sell to Cover
2026-02-02
$35,281
|
||||||
| AKBA |
Akebia Therapeutics, Inc.
|
Officer • SVP, Chief Legal Officer
Sell to Cover
|
2026-02-02 | $35,281 | S | Form 4 |
|
AKBA
S
Akebia Therapeutics, Inc.
Rucci Carolyn M.
• Officer • SVP, Chief Legal Officer
Sell to Cover
2026-02-02
$38,286
|
||||||
| AKBA |
Akebia Therapeutics, Inc.
|
Officer • SVP, Chief Legal Officer
Sell to Cover
|
2026-02-02 | $38,286 | S | Form 4 |
|
AKBA
S
Akebia Therapeutics, Inc.
Grund Nicholas
• Officer • Chief Commercial Officer
Sell to Cover
2026-02-02
$43,429
|
||||||
| AKBA |
Akebia Therapeutics, Inc.
|
Officer • Chief Commercial Officer
Sell to Cover
|
2026-02-02 | $43,429 | S | Form 4 |